Neoplasia/BPH

	Fecal microbiota transplantation: a novel strategy and challenges in the adjuvant treatment of bladder Cancer. Front Microbiol Liu X, Chen Z, Lu Y, Wu Y, Huang Y, Zhang Y, Li M, Feng N. PMID: 41710924 [PubMed]
	In vitro cytotoxicity of medicinal plants used in prostate cancer management in Africa: a systematic review. Trop Med Health Bwesigye T, Nerima B, Kyambadde J, Mulindwa J, Byarugaba I, Sekandi P. PMID: 41709315 [PubMed - as supplied by publisher]
	Development and Validation of an AI-Assisted Predictive Model Integrating R2* Mapping and Clinical Indicators for Clinically Significant Prostate Cancer. Cancer Med Li X, Shi Y, Fang J, Zhang R, He X, Ai G. PMID: 41709083 [PubMed - indexed for MEDLINE]
	Physical activity at baseline and risk of prostate cancer grade reclassification on active surveillance: results from a prospective cohort study. Prostate Cancer Prostatic Dis Higgins MI, Su ZT, Mamawala M, Jing Y, Landis PK, Alshak MN, Grutman AJ, Rivera Lopez CA, Pavlovich CP, Trock BJ. PMID: 41708991 [PubMed - as supplied by publisher]
	Corrigendum to "Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-GuÃ©rin (BCG) in BCG-naÃ¯ve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials" [Eur. Urol. (2025)]. Eur Urol Scilipoti P, Zaurito P, Longoni M, Colecchia M, Montorsi F, Salonia A, Mercinelli C, Maiorano B, Necchi A, Briganti A, Moschini M. PMID: 41708452 [PubMed - as supplied by publisher]
	MRI-Based Habitat Radiomics for Predicting Postoperative Recurrence in Nonmetastatic Clear Cell Renal Cell Carcinoma. Acad Radiol Yi S, Jia T, Bai X, Kang H, Zhao J, Liu B, Li C, Wen X, Xu H, Ning X, Liu H, Cui M, Zhou S, Ma Y, Xie L, Zhao H, Ma X, Wang H. PMID: 41708388 [PubMed - as supplied by publisher]
	Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study. Biol Pharm Bull Okada N, Kimura H, Ozaki M, Tamura M, Ochi F, Sasaki T, Takimoto T, Kitahara T. PMID: 41708090 [PubMed - indexed for MEDLINE]
	To Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database. Int J Urol Kobayashi S, Shiota M, Onozawa M, Taguchi S, Yamamoto Y, Sakamoto S, Kawai T, Nakagawa T, Hinotsu S, Eto M, Kume H, Japan Study Group of Prostate Cancer (J. PMID: 41708074 [PubMed - indexed for MEDLINE]
	Molecular insights for the tumor suppressor role of SPOP in prostate cancer. Biochim Biophys Acta Rev Cancer Yan P, Xue X, Hou T, Wang J, Jiang W, Wang Z, Inuzuka H, Wei W. PMID: 41707797 [PubMed - as supplied by publisher]
	Optimising on-treatment review schedules: A narrative review of acute toxicities in ultra-hypofractionated stereotactic ablative body radiotherapy (SABR) for localised prostate cancer. Radiography (Lond) McKenna G, Flood T. PMID: 41707610 [PubMed - as supplied by publisher]
	Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, Rodriguez-Vida A, Zhang Z, Atduev V, Göger YE, Rausch S, Kang SH, Loriot Y, Bedke J, Galsky MD, O'Donnell PH, von Amsberg G, Alimohamed N, Sulimka G, Gupta S, Paramonov V, Nakane K, Mihm M, Meng C, Huang CD, Ramamurthy C, Homet Moreno B, Ullén A, KEYNOTE-905/EV-303 Investigators. PMID: 41707170 [PubMed - as supplied by publisher]
	Not all progression is equal. Cancer Venkateswaran S, Mantena RV, Willmann J, Zhang YH, Dee EC, Iyengar P. PMID: 41707059 [PubMed - indexed for MEDLINE]
	Integrating machine learning and mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies. Int J Surg Xu C, Dong Y, Li J, Liao X, Zhang C, Lv C, Li C, Liu Y, Yao L, Zhou L. PMID: 41706814 [PubMed - as supplied by publisher]
	Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization study. Int J Surg Xu B, Xiang P, Yang X, Zhang T, Liu Y, Tang F, He Z, Zhou J. PMID: 41706624 [PubMed - as supplied by publisher]
	Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial. JAMA Cardiol Patel SA, Yadalam AK, van Assen M, Cantu SM, Onnis C, Zheng B, Koo A, Goyal S, Liu Y, Liu C, Sebastian NT, Dhere VR, Hershatter BW, Patel PR, Chaudagar K, Stillman AE, De Cecco CN, Sanda MG, Jani AB, Mandawat A. PMID: 41706486 [PubMed - as supplied by publisher]
	Minimally Invasive Surgery in Solitary Kidneys with Renal Tumors: A Surgical Evolution. Curr Urol Rep Spezzi Roncero LG, Romeo A, Garcia-Marchiñena PA, Jurado AM. PMID: 41706412 [PubMed - in process]
	Palliative Intra-Arterial Chemotherapy Without Radiotherapy for Elderly Patients With Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Comparison With Radical Cystectomy and Best Supportive Care. Int J Urol Kusano S, Tobu S, Yukimoto M, Yamaguchi Y, Maeda A, Kakinoki Y, Kakinoki H, Kawasaki M, Yamaguchi K, Egashira Y, Noguchi M. PMID: 41705566 [PubMed - indexed for MEDLINE]
	Incidental prostate cancer following surgery for benign prostatic hyperplasia: a cohort study. Arch Ital Urol Androl Pedrosa R, Lorigo J, Guerra AJ, Figueiredo B, Quaresma V, Eliseu M, Temido P, Figueiredo A. PMID: 41705465 [PubMed - as supplied by publisher]
	Soluble immune checkpoint proteins as predictive biomarkers for lymph node metastases in penile cancer. Front Immunol Glombik D, Carlsson J, Kirrander P, Davidsson S. PMID: 41705256 [PubMed - indexed for MEDLINE]
	Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting nivolumab-responsive renal cell carcinoma. Front Immunol Wang M, Dong W, Chen J, Wu P, Wang Y, Zhang X, Cao Y, Wang Z, Zhong Z, Zhong Y. PMID: 41705252 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 185603

Page 1 of 9281



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy